{"id":"W2892288216","doi":"10.1016/j.jaci.2018.08.022","title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","year":2018,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":678,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"Janssen Biotech; Allergan; LEO Pharma; Eli Lilly and Company; Galderma; Dermira; Celgene; Regeneron Pharmaceuticals; Novartis; Maruho; Amgen; Pfizer; AbbVie; Sanofi; Merck","keywords":"Dupilumab; Atopic dermatitis; SCORAD; Filaggrin; Eczema Area and Severity Index; Medicine; Placebo; Loricrin; Internal medicine; Immunology; Pathology; Psoriasis; Dermatology Life Quality Index; Biology; Keratinocyte; Involucrin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001174038,0.0001030193,0.0004680678,0.00008801869,0.00005499559,0.00001076358,0.00006487314,0.0001820641,0.00002931854],"category_scores_gemma":[0.0001854418,0.00006870118,0.00004969842,0.00004379321,0.0007861219,0.0001097898,0.00004135807,0.0002997422,0.000003277599],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001183799,"about_ca_system_score_gemma":0.00009406285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006154397,"about_ca_topic_score_gemma":0.00002534172,"domain_scores_codex":[0.9988531,0.0001379613,0.0006374768,0.0001157092,0.0000893515,0.0001663648],"domain_scores_gemma":[0.9990765,0.0001930587,0.0003290186,0.00009772674,0.0002161763,0.00008756368],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001697064,0.0003882493,0.9851759,0.00005024426,0.0009520046,0.0006159412,0.0002290658,6.062674e-8,0.000007898186,0.0001479414,0.0002938299,0.01044177],"study_design_scores_gemma":[0.005002865,0.003091302,0.9845961,0.0003509149,0.00008766885,0.005553049,0.0002489385,0.000006037828,0.00001921128,0.0001932163,0.0007770761,0.00007366561],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945462,0.004374399,0.000005186247,0.0005294587,0.0002272572,0.0001019074,0.000001351985,0.00000663772,0.000207645],"genre_scores_gemma":[0.9973966,0.001870788,0.0001302469,0.0004253472,0.00008394244,0.000001866405,0.000001878503,0.000006816689,0.00008253041],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01036811,"threshold_uncertainty_score":0.2896499,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008808492719377024,"score_gpt":0.2738651296625087,"score_spread":0.2650566369431317,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}